secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aurinia Pharmaceuticals Inc. (AUPH)
CIK:        0001600620
Form:       8-K
Filed at:   2021-07-19T23:59:59+00:00
Accession:  0001628280-21-013970
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aurinia voluntarily delists from TSX effective July 30, 2021; continues on Nasdaq
--------------------------------------------------------------------------------

- Delisting from Toronto Stock Exchange effective July 30, 2021; no shareholder approval required.
- Nasdaq accounted for ~94% of daily trading volume over past 12 months.
- Dual listing costs and administrative burden no longer justified given low TSX volume.
- Common shares continue trading on Nasdaq under ticker AUPH.
- Canadian brokers can trade Nasdaq-listed shares; shareholder value unaffected.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1600620/000162828021013970/0001628280-21-013970-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1600620/000162828021013970/auph-20210716.htm
  HTML page:      https://secwatch.observer/filing/0001628280-21-013970

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer